Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00082732 · ClinicalTrials.gov registry record · Phase 1
Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00082732: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00082732 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00082732, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
RATIONALE: A low-fat, high-fiber diet that includes soy protein may prevent disease progression in patients with hormone-refractory prostate cancer. Nutrition counseling may help motivate patients to follow this diet. PURPOSE: Randomized phase I trial to study the effectiveness of behavior-based dietary interventions, such as receiving nutrition counseling, in helping patients who have hormone-refractory prostate cancer follow a low-fat, high-fiber, soy-supplemented diet.
Interventions
- BEHAVIORAL behavioral dietary intervention
- DIETARY_SUPPLEMENT dietary intervention
- PROCEDURE therapeutic dietary intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2000-07-28 |
| Est. Completion | 2006-02-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00082732
The ClinicalTrials.gov registry entry for NCT00082732 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which behavioral dietary intervention is the first listed.
NCT00082732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00082732 about?
NCT00082732 is a clinical study titled "Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer". RATIONALE: A low-fat, high-fiber diet that includes soy protein may prevent disease progression in patients with hormone-refractory prostate cancer. Nutrition counseling may help motivate patients to follow this diet. PURPOSE: Randomized phase I trial to study the effectiveness of behavior-based di...
What is the current status of trial NCT00082732?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2000-07-28. Estimated completion is 2006-02-27.
What interventions are being tested in trial NCT00082732?
The interventions under investigation include: behavioral dietary intervention (BEHAVIORAL), dietary intervention (DIETARY_SUPPLEMENT), therapeutic dietary intervention (PROCEDURE).
Who is sponsoring clinical trial NCT00082732?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.